Diabetes mellitus and Alzheimer's disease: glycation as a biochemical link
Dear Sir, Advanced glycation end products (AGE) are a family of complex, evolved post-translational modifications initiated by the condensation of reducing sugars with protein amino groups via the Maillard reaction [1] . Considerable evidence suggests that glycation of proteins and AGE play a role in the pathological processes of diabetes. Recently, several independent investigations have revealed that AGE-relate modifications are also found in Alzheimer's disease, the leading cause of senile dementia [2] . In Alzheimer's disease, the protein components of the pathological lesions (i. e., neurofibrillary tangles and senile plaques) contain AGE modifications and these post-translational events are thought to be involved in the formation of the lesions [3] [4] [5] [6] . Additionally, together with evidence of free radical damage in Alzheimer's disease [2, 7, 8] , these findings suggest that, as with diabetes, glycoxidation (i. e., glycation-related oxidative processes) is likely to play a role in the pathogenesis of Alzheimer's disease [2] .
The occurrence of AGE modifications in both diabetes and Alzheimer's disease might lead one to predict a higher-thanexpected incidence of concurrent diabetes and Alzheimer's disease. However, predictions of diabetes and concurrent Alzheimer's disease unfortunately must await epidemiological analyses that consider the lowered life expectancy of uncontrolled diabetic patients, in whom glycation is greatest. Conversely, life-long glycation may result in compensations, leading instead to discordance of Alzheimer's disease and diabetes. Obviously, further investigation is essential to bear out either association.
Whether glycation in Alzheimer's disease is a primary or secondary event is controversial [9] . However, the presence of AGE modifications in the earliest pathological changes in Alzheimer's disease indicates that AGE-modification, in synergy with oxidative modifications, are likely early in vivo events [2, 10] . Indeed, other factors may initiate Alzheimer's disease, predisposing them toward glycoxidative damage, and such an interpretation is attractive when one considers the spoCorresponding author: Dr. M. A. Smith, Institute of Pathology, Case Western Reserve University, Cleveland, Ohio 44106-2622, USA radic onset of most cases and the individual variation that includes mentally normal individuals with abundant senile plaques. Demonstration of links between Alzheimer's disease and metabolic disturbances of glucose metabolism or imbalances in free radical or reactive oxygen species detoxification may clarify these issues. In any event, the commonality of AGE modifications and free radical damage in diabetes and Alzheimer's disease suggests that common therapeutic rationales might be considered. 
